Biolegend, 324212, Alexa Fluor® 647 anti-human CD326 (EpCAM) Antibody
100tests
Catalog Number: 324212
Send an RFQ.
Category
Loading…
| Verified Reactivity | Human |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Immunogen | DU.4475 breast carcinoma |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA) |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 647 under optimal conditions. |
| Concentration | Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.) |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality tested ICC - Verified SB - Reported in the literature, not verified in house |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µL per million cells in 100 µL staining volume or 5 µL per 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 647 has a maximum emission of 668 nm when it is excited at 633nm / 635nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Excitation Laser | Red Laser (633 nm) |
|---|
| Application Notes | Additional reported applications (for the revelant formats) include: immunofluorescence, immunohistochemistry3, and spatial biology (IBEX)4,5. |
|---|
| Additional Product Notes | Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH). |
|---|
| Application References(PubMed link indicates BioLegend citation) | Lammers R, et al. 2002. Exp. Hematol. 30:537. Schultz LD, et al. 2010. P. Natl. Acad. Sci. USA 107:13022. PubMed Human Protein Atlas http://www.proteinatlas.org/ENSG00000119888/antibody (IHC) Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed |
|---|
| Product Citations | Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed Qin XY, et al. 2023. Cell Death Dis. 14:358. PubMed Liang J, et al. 2022. J Clin Invest. 132: . PubMed Martínez-Sabadell A, et al. 2022. Cell Rep. 41:111430. PubMed Estrada HQ, et al. 2022. Inflamm Bowel Dis. 28:667. PubMed Bhatia S, et al. 2022. Cancer Res. 82:1174. PubMed Meirelles K, et al. 2012. Proc Natl Acad Sci U S A. 109:2358. PubMed Pham K, et al. 2016. Am J Pathol. 186: 1537-1546. PubMed Qin XY, et al. 2020. Cell Death Dis. 0.504166667. PubMed Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed Ebisudani T, et al. 2021. Cell Reports. 35(10):109218. PubMed Kitajima S, et al. 2019. Cancer Discov. 9:34. PubMed Robertson N, et al. 2020. J Biol Chem. . PubMed Campisi M, et al. 2020. Front Immunol. 1.909722222. PubMed Csizmar CM, et al. 2019. J Am Chem Soc. 141:251. PubMed Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed Liu T, et al. 2019. Oncol Lett. 18:2262. PubMed Stallcop LE, et al. 2018. Lab Chip. 18:451. PubMed Arenas EJ, et al. 2021. Nat Commun. 12:1237. PubMed Vanslambrouck JM, et al. 2022. Nat Commun. 13:5943. PubMed Zhou J, et al. 2011. J Vis Exp. 55: 3322. PubMed Liu X, et al. 2021. iScience. 24(6):102551. PubMed Freire‐Pritchett P et al. 2017. eLife. 6 pii: e21926. PubMed Sun Q, et al. 2018. J Clin Invest. 128:531. PubMed Morris EJ, et al. 2020. Cell Rep. 30:3605. PubMed Robertson N, et al. 2020. J Biol Chem. 295:18436. PubMed |
|---|
| RRID | AB_756086 (BioLegend Cat. No. 324212) |
|---|
| Structure | Type I transmembrane protein, contains six disulfide bridges, one THYRO domain, approximate molecular weight 40 kD. |
|---|
| Distribution | Highly expressed in bone marrow, colon, lung, and most normal epithelial cells. Also highly expressed on carcinomas of gastrointestinal origin. Expressed during early erythrogenesis. |
|---|
| Function | Homotypic calcium-independent cell adhesion. CD326 is believed to be involved in carcinogenesis by its ability to induce genes involved in cellular metabolism and proliferation. |
|---|
| Modification | Glycosylated. |
|---|
| Cell Type | Embryonic Stem Cells, Epithelial cells |
|---|
| Biology Area | Cell Biology, Immunology, Stem Cells |
|---|
| Molecular Family | Adhesion Molecules, CD Molecules |
|---|
| Antigen References | 1. Strnad J, et al. 1989. Cancer Res. 49:314. 2. Munz M, et al. 2004. Oncogene 23:5748. 3. Rao CG, et al. 2005. Int. J. Oncol. 27:49. |
|---|
| Gene ID | 4072 |
|---|
| UniProt | View information about CD326 on UniProt.org |
|---|
| Clone | 9C4 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Ep-CAM, tumor associated calcium signal transducer 1, epithelial cell surface antigen, epithelial glycoprotein 2, EGP2, adenocarcinoma associated antigen, TROP1 |
|---|
| Isotype | Mouse IgG2b, κ |
|---|
